Clovis Oncology, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Clovis Oncology, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Option Exercise | M | 0.00 | 725 | 0 | 2,175 | |
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Option Exercise | M | 0.00 | 1,250 | 0 | 0 | |
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Sell | S | 8.17 | 313 | 2,557 | 3,099 | 3.4 K to 3.1 K (-9.17 %) |
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Buy | M | 0.00 | 725 | 0 | 3,412 | 2.7 K to 3.4 K (+26.98 %) |
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Sell | S | 8.17 | 539 | 4,404 | 2,687 | 3.2 K to 2.7 K (-16.71 %) |
| Feb 19 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Buy | M | 0.00 | 1,250 | 0 | 3,226 | 2 K to 3.2 K (+63.26 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 18,500 | 0 | 55,500 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Option Exercise | M | 0.00 | 5,625 | 0 | 44,990 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 7.97 | 9,255 | 73,762 | 42,945 | 52.2 K to 42.9 K (-17.73 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 18,500 | 0 | 52,200 | 33.7 K to 52.2 K (+54.90 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 7.97 | 1,431 | 11,405 | 33,700 | 35.1 K to 33.7 K (-4.07 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 3,068 | 0 | 35,131 | 32.1 K to 35.1 K (+9.57 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Sell | S | 7.97 | 1,187 | 9,460 | 32,063 | 33.3 K to 32.1 K (-3.57 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Gross Paul Edward | See Remarks | Buy | M | 0.00 | 2,557 | 0 | 33,250 | 30.7 K to 33.3 K (+8.33 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Option Exercise | M | 0.00 | 7,250 | 0 | 21,750 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Option Exercise | M | 0.00 | 1,563 | 0 | 12,500 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Sell | S | 7.97 | 4,317 | 34,406 | 7,126 | 11.4 K to 7.1 K (-37.73 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Buy | M | 0.00 | 7,250 | 0 | 11,443 | 4.2 K to 11.4 K (+172.91 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Sell | S | 7.97 | 931 | 7,420 | 4,193 | 5.1 K to 4.2 K (-18.17 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Harding Thomas C. | See Remarks | Buy | M | 0.00 | 1,563 | 0 | 5,124 | 3.6 K to 5.1 K (+43.89 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 18,500 | 0 | 55,500 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 5,625 | 0 | 44,990 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 7.97 | 9,254 | 73,754 | 46,990 | 56.2 K to 47 K (-16.45 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 18,500 | 0 | 56,244 | 37.7 K to 56.2 K (+49.01 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 7.97 | 1,187 | 9,460 | 37,744 | 38.9 K to 37.7 K (-3.05 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 2,557 | 0 | 38,931 | 36.4 K to 38.9 K (+7.03 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 7.97 | 1,431 | 11,405 | 36,374 | 37.8 K to 36.4 K (-3.79 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 3,068 | 0 | 37,805 | 34.7 K to 37.8 K (+8.83 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 18,500 | 0 | 55,500 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,750 | 0 | 29,994 | |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 7.97 | 9,822 | 78,281 | 68,712 | 78.5 K to 68.7 K (-12.51 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 18,500 | 0 | 78,534 | 60 K to 78.5 K (+30.82 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 7.97 | 1,991 | 15,868 | 60,034 | 62 K to 60 K (-3.21 %) |
| Feb 03 2021 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,750 | 0 | 62,025 | 58.3 K to 62 K (+6.44 %) |